Prognia
Drug Database
🇺🇸US · FDA ApprovedPrescriptionANDA090159-001

ABACAVIR SULFATE AND LAMIVUDINE(ABACAVIR SULFATE)

Nucleoside and nucleotide reverse transcriptase inhibitors; Antivirals for treatment of HIV infections, combinations

Manufacturer: AUROBINDO PHARMA LTD

FDA Approval: 15/11/2018

Route: ORAL · TABLET

Active Ingredients

ABACAVIR SULFATE EQ 600MG BASE; LAMIVUDINE 300MG

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about ABACAVIR SULFATE AND LAMIVUDINE — check interactions with your patient's full medication list, get dosing recommendations with renal/hepatic adjustments, and explore guideline-cited evidence.

Medical disclaimer: This drug information is intended for qualified healthcare professionals only. Always verify with the official FDA prescribing information before clinical use.